G9649 HCPCS Level II code: Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis…
G9649 is the HCPCS code for “Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or…” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9649Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
Short description: Psor as doc spc bm
HCPCS · United States
Medicare details
The indicators CMS publishes with G9649 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2016
Where G9649 sits
- 1G codesProcedures and professional services
- 2Active code G9649Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9649 mean?
G9649 is the HCPCS code for “Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9649?
CMS lists G9649’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9649
All G codesG9643Elective surgeryG9644Patients who abstained from smoking prior to anesthesia on the day of surgery or procedureG9645Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedureG9646Patients with 90 day mrs score of 0 to 2G9647Patients in whom mrs score could not be obtained at 90 day follow-upG9648Patients with 90 day mrs score greater than 2G9650Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options)…G9651Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity…G9652Patient has been treated with a systemic or biologic medication for psoriasis for at least six monthsG9653Patient has not been treated with a systemic or biologic medication for psoriasis for at least six monthsG9654Monitored anesthesia care (mac)G9655A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used